NCT06779799 Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)
| NCT ID | NCT06779799 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Dysphonia |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-12-01 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this multicenter retrospective observational study is to provide an inventory of the specific and non specific cord vocal lesions that can cause dysphonia in patients with systemic autoimmune diseases. The main question it aims to answer is: * What are the main cord vocal lesions responsible for dysphonia in patients with a systemic autoimmune disease? * Is there a diagnosis delay regarding those lesions? * How are those lesions managed? Participants suffering from dysphonia in a context of a systemic autoimmune disease will be identified, with a review of their medical record.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or older * With a systemic autoimmune disease : rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, primary Sjogren disease, sarcoidosis, vasculitis, myositis, Still disease, Sharp syndrome. * Suffering from dysphonia. * With a cord vocal/laryngeal lesion highlighted. Exclusion Criteria: * Patients under the age of 18 years * Dysphonia due to a cord vocal palsy related to a neurological condition or malignancy * History of cervical radiation * History of oro-tracheal intubation * Laryngeal cancer * Participation deny * Impossibility of consent * Patients with legal protection
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06779799 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dysphonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06779799 currently recruiting?
Yes, NCT06779799 is actively recruiting participants. Contact the research team at alice.tison@chu-brest.fr for enrollment information.
Where is the NCT06779799 trial being conducted?
This trial is being conducted at Brest, France.
Who is sponsoring the NCT06779799 clinical trial?
NCT06779799 is sponsored by University Hospital, Brest. The trial plans to enroll 150 participants.